What is Precision Diagnostics?
Founded in 2011 and headquartered in San Diego, California, Precision Diagnostics operates within the critical healthcare sector, focusing on advanced clinical urine and oral fluid drug testing solutions. The company's commitment to ultra-high sensitivity testing positions it as a key player in diagnostic services, catering to needs that demand precision and reliability in drug detection.
How much funding has Precision Diagnostics raised?
Precision Diagnostics has raised a total of $16.5M across 2 funding rounds:
Debt
$14.5M
Debt
$2M
Debt (2015): $14.5M with participation from BelHealth Investment Partners
Debt (2020): $2M led by PPP
Key Investors in Precision Diagnostics
BelHealth Investment Partners
BelHealth Investment Partners is a premier growth partner focused on building healthcare businesses, typically investing between $20 million and $50 million per platform. Their extensive experience in healthcare transactions positions them as a strategic backer for companies like Precision Diagnostics.
PPP
Public-Private Partnership
What's next for Precision Diagnostics?
The recent major strategic investment into Precision Diagnostics signals a phase of accelerated growth and market expansion. This capital infusion is expected to bolster the company's technological advancements and broaden its service offerings in the competitive clinical diagnostics landscape. The company's trajectory, marked by consistent financial backing, suggests a strategic focus on scaling operations and solidifying its market leadership in specialized drug testing.
See full Precision Diagnostics company page
